Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
GlobeNewswire
Company announces results from a Phase IV study of Mydcombi designed to characterize the efficacy and duration of the lowest..